Inspired by nature. Refined by science.
Next Generation Psychedelics for the Mind and Cannabinoids for the Body
Extending and Enhancing Quality of Life for Patients and Their Families
Deep Expertise in Synthetic Chemistry and Biology
A Powerful, Bespoke AI Engine to Identify the Best Molecules
Enveric Biosciences is leveraging its discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body. By harnessing the power of synthetic biology and chemistry, the company is optimizing what nature created to improve the human condition.
Enveric is focused on synthesizing novel, tailored and highly commercial derivative molecules based on classic psychedelics.
Enveric seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies.
Enveric has a robust pipeline with multiple data points expected in 2022 for radiodermatitis and glioblastoma.